Joseph Jimenez, CEO of drug maker Novartis AG, speaks during a news conference in Basel, Switzerland, Wednesday, Jan. 29, 2014. The Basel, Switzerland-based company said it had a net profit of US ... more 
Joseph Jimenez, CEO of drug maker Novartis AG, speaks during a news conference in Basel, Switzerland, Wednesday, Jan. 29, 2014. The Basel, Switzerland-based company said it had a net profit of US dollar 2.029 billion attributable to shareholders in the final three months of 2013, up from a restated US dollar 1.985 billion in the same period the previous year. Jimenez said Novartis delivered a strong performance in 2013, growing both net sales and core operating income in constant currencies while absorbing patent expirations. (AP Photo/Keystone, Steffen Schmidt) less 
1 / 1
Associated Press | Photo By Keystone, Steffen Schmidt
Wed, Jan 29, 2014 6:12 AM EST